The rationale was explained at the AGM. mRNA vaccines or drugs induce inflammation courtesy of the TLR-7 receptor. Moderna and Pfizer/BioNTech have exclusive licence to the technology invented by the two recent Nobel Prize winners to help block the inflammatory response. All other companies interested in mRNA vaccines or drugs have been locked out of that technology and need to find another way to allow them onto the market. NOX believes that it has the only other way. So, I take it from that explanation that prospective Licensees are everyone else apart from Moderna and Pfizer/BioNTech.
Ann: mRNA Vaccine Enhancer Shows Inflammation Reduction, page-46
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $23.37M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 8.0¢ | 7.9¢ | $4.146K | 51.97K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79733 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 148300 | 2 |
View Market Depth
| Last trade - 16.10pm 31/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.9¢ |
Change
0.000 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 7.9¢ | 7.9¢ | 2000 | ||
| Last updated 14.36pm 31/05/2024 ? | |||||
| NOX (ASX) Chart |